The notoriously private Chemist Warehouse hosted a dinner for a select group of investors, sources said, in an affair arranged with the help of Macquarie Capital.
It was a rare appearance by a group that only speaks on its terms. It gets invited to just about every major retail sector conference in the world – and usually says no. The last time we saw it presenting to investors was at a Credit Suisse Asia equities shindig in 2019.
It’s interesting timing. Chemist Warehouse had bankers in pitching for roles in its potential IPO two months ago, and now it is lifting its bonnet for fund managers.
Australian laboratory services provider 360Biolabs is seeking to capitalise on red-hot demand for biotech research testing companies and their service providers.
